Speeding innovation for industry
Micro and nanotechnology for healthcare
When it comes to detecting the presence of viruses in the air, Bertin Technologies' Coriolis Nano is a particularly effective weapon. The device was initially developed to head off bacteriological threats like anthrax attacks. The current pandemic has given it a new mission: detecting coronavirus particles in the air. The compact and very quiet portable system, which collects airborne particles, bacteria, and viruses and measures individuals' risk of exposure, is based on a technology developed and patented by Leti in research conducted through a joint lab with Bertin Technologies. It is especially useful in hospitals and other medical settings.
The collector is made up of a tube through which the air flows at a rate of 10 liters per minute, representative of the average person's breathing. The device has already proven effective on respiratory viruses and was tested on SARS-Cov-2. Once the air is inside the device, an electrostatic field instantly charges any particles present, orienting them toward one of two electrodes. Particles of all sizes (even less than 1 micron) can be captured. And, because there is no filter, the device's yields do not diminish over time and it is easier to recover the samples for more advanced lab tests.
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.